ArticleJournal of the Royal Society of Medicine2014
Tendering and value-based pricing: lessons from Italy on human papilloma virus vaccines.
Article in Journal of the Royal Society of Medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Are the Two Human Papillomavirus Vaccines Really Similar? A Systematic Review of Available Evidence: Efficacy of the Two Vaccines against HPV.Journal of immunology research · 2015Pooled it
- Impact of national volume-based procurement reform on the markup of pharmaceutical firms: an event study.Cost effectiveness and resource allocation : C/E · 2025Article
- A concept for multi-winner tenders for medicinal products with balancing between efficient prices, long-term competition and sustainability of supply.Frontiers in medicine · 2023Article
- Impact of changes in the methodology of external price referencing on medicine prices: discrete-event simulation.Cost effectiveness and resource allocation : C/E · 2020Article
- Vaccine Prices: A Systematic Review of Literature.Vaccines · 2020Review
- Pricing of HPV vaccines in European tender-based settings.The European journal of health economics : HEPAC : health economics in prevention and care · 2019Article
- Factors associated with the pricing of childhood vaccines in the U.S. public sector.Health economics · 2018Article
- Drug tendering: drug supply and shortage implications for the uptake of biosimilars.ClinicoEconomics and outcomes research : CEOR · 2017Review
- Pricing of forthcoming therapies for hepatitis C in Europe: beyond cost-effectiveness?The European journal of health economics : HEPAC : health economics in prevention and care · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.